Evidence map›Paper›PMID 30324504›Full record

ArticleJournal of molecular modeling2018

Application of molecular dynamics simulations to design a dual-purpose oligopeptide linker sequence for fusion proteins.

Ehsan Rezaie, Mozafar Mohammadi, Amirhossein Sakhteman, Peyman Bemani, Sajjad Ahrari

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ehsan RezaieApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mozafar MohammadiApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. mohammadi83@live.com.
Amirhossein SakhtemanSchool of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Peyman BemaniDepartment of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
Sajjad AhrariDepartment of Pharmaceutical Biotechnology, Pharmaceutical Science Research Center, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteins are often monitored by combining a fluorescent polypeptide tag with the target protein. However, due to the high molecular weight and immunogenicity of such tags, they are not suitable choices for combining with fusion proteins such as immunotoxins. In this study, we designed a polypeptide sequence with a dual role (it acts as both a linker and a fluorescent probe) to use with fusion proteins. Two common fluorescent tag sequences based on tetracysteine were compared to a commonly used rigid linker as well as our proposed dual-purpose sequence. Computational investigations showed that the dual-purpose sequence was structurally stable and may be a good choice to use as both a linker and a fluorescence marker between two moieties in a fusion protein.

Indexed as

Computer-Aided DesignFluorescent DyesMolecular Dynamics SimulationRecombinant Fusion ProteinsHumansFluorescent DyesRecombinant Fusion ProteinsFusion proteinImmunotoxinMD simulationOligopeptide linkerTetracysteine tag

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.